Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA510701
Max Phase: Preclinical
Molecular Formula: C22H32O3
Molecular Weight: 344.50
Molecule Type: Small molecule
Associated Items:
ID: ALA510701
Max Phase: Preclinical
Molecular Formula: C22H32O3
Molecular Weight: 344.50
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 7-Deacetoxyyanuthone
Synonyms from Alternative Forms(1):
Canonical SMILES: CC(C)=CCC/C(C)=C/CC/C(C)=C/C[C@@]12O[C@@H]1[C@H](O)C(C)=CC2=O
Standard InChI: InChI=1S/C22H32O3/c1-15(2)8-6-9-16(3)10-7-11-17(4)12-13-22-19(23)14-18(5)20(24)21(22)25-22/h8,10,12,14,20-21,24H,6-7,9,11,13H2,1-5H3/b16-10+,17-12+/t20-,21-,22+/m1/s1
Standard InChI Key: DKOXVDVXOYHFHV-ITGDQCKOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 344.50 | Molecular Weight (Monoisotopic): 344.2351 | AlogP: 4.82 | #Rotatable Bonds: 8 |
Polar Surface Area: 49.83 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.46 | CX Basic pKa: | CX LogP: 5.07 | CX LogD: 5.07 |
Aromatic Rings: 0 | Heavy Atoms: 25 | QED Weighted: 0.51 | Np Likeness Score: 2.90 |
1. Maskey RP, Grün-Wollny I, Laatsch H.. (2005) Sorbicillin analogues and related dimeric compounds from Penicillium notatum., 68 (6): [PMID:15974609] [10.1021/np040137t] |
2. Liu D, Yang A, Wu C, Guo P, Proksch P, Lin W.. (2014) Lipid-lowering effects of farnesylquinone and related analogues from the marine-derived Streptomyces nitrosporeus., 24 (22): [PMID:25304895] [10.1016/j.bmcl.2014.09.049] |
Source(1):